Organization Overview
Historical Acquisition Tree
Alternative names
Key: Alcon (51) Acquired (1)
atropine (2016)
betaxolol (kerlone) (NDA)
brimonidine (alphagan) (2013)
brinzolamide (azopt) (1998 NDA)
calcium chloride (2008)
carbachol (miostat) (1972 NDA)
chloramphenicol (chloromycetin) (1973)
chymotrypsin (zolyse) (1959 NDA)
cyclopentolate (cyclogyl) (1974 NDA)
dexamethasone (1973)
finafloxacin (xtoro) (2014 NDA)
fluorescein (2006)
fluorometholone (fml) (1989)
gentamicin (garamycin) (1985)
glucose monohydrate (1981)
glutathione (1981)
idoxuridine (herplex) (1963)
iophendylate (Pantopaque) (1980)
isosorbide (isordil) (1974)
ketotifen (zaditor) (1999)
levobetaxolol (betaxon) (2000 NDA)
levobunolol (betagan) (1996)
loteprednol (lotemax) (2018)
magnesium (2008)
naphazoline (visine) (1974)
neomycin (NDA)
nepafenac (nevanac) (2005 NDA)
olopatadine (patanol) (2015)
oxiglutatione (2008 NDA)
pheniramine (Tripoton) (1994)
phenylephrine (Prefrin) (1975)
pilocarpine (ocusert) (1984)
polymyxin b sulfate (poly-rx) (1974)
potassium chloride (klor-con) (1981)
povidone-iodine (betadine) (1986 NDA)
prednisolone (hydeltra) (1991)
prednisone (meticorten) (1973)
proparacaine (ophthaine) (1971)
sodium acetate (1997)
sodium bicarbonate (1981)
sodium chloride (1981)
sodium citrate (1997)
sodium phosphate (1981)
sulfacetamide (sultrin) (1971)
suprofen (Profenal) (1988 NDA)
tetracaine (pontocaine) (2016)
timolol (blocadren) (2010)
tobramycin (nebcin) (1994)
travoprost (travatan) (2001 NDA)
triamcinolone (kenalog) (2007)
tropicamide (mydriacyl) (1960 NDA)
urea (1973)
Key: Alcon (33) Acquired (1)
acetaminophen (tylenol) (3 trials)
azelastine (astelin) (3 trials)
bimatoprost (lumigan) (4 trials)
brimonidine (alphagan) (17 trials)
brinzolamide (azopt) (43 trials)
difluprednate (durezol) (4 trials)
fluticasone (cutivate) (1 trial)
ketorolac (acuvail) (4 trials)
ketotifen (zaditor) (2 trials)
latanoprost (xalatan) (26 trials)
levofloxacin (levaquin) (1 trial)
Key: Alcon (7) Acquired (1)
Atrophy (Phase 3)
Blepharitis (Phase 3)
Cataract (Phase 4)
Central Serous Chorioretinopathy (Phase 2)
Choroidal Neovascularization (Phase 3)
Communicable Diseases (Phase 2)
Conjunctivitis (Phase 4)
Conjunctivitis, Allergic (Phase 4)
Conjunctivitis, Bacterial (Phase 4)
Conjunctivitis, Inclusion (Phase 2)
Corneal Edema (Phase 4)
Diabetic Retinopathy (Phase 3)
Dry Eye Syndromes (Phase 4)
Edema (Phase 4)
Epiretinal Membrane (Phase 4)
Eye Diseases (Phase 2)
Eye Injuries (Phase 2)
Geographic Atrophy (Phase 3)
Glaucoma (Phase 4)
Glaucoma, Angle-Closure (Phase 4)
Glaucoma, Open-Angle (Phase 4)
Hydrophthalmos (Phase 3)
Hypersensitivity (Phase 1)
Hypertension (Phase 4)
Infections (Phase 2)
Inflammation (Phase 4)
Iridocyclitis (Phase 3)
Keratitis (Phase 3)
Keratoconjunctivitis Sicca (Phase 4)
Low Tension Glaucoma (Phase 4)
Macular Degeneration (Phase 3)
Macular Edema (Phase 2)
Myopia (Phase 3)
Neovascularization, Pathologic (Phase 3)
Ocular Hypertension (Phase 4)
Otitis (Phase 3)
Otitis Externa (Phase 3)
Otitis Media (Phase 3)
Otitis Media with Effusion (Phase 3)
Pain, Postoperative (Phase 4)
Refractive Errors (Phase 4)
Retinal Diseases (Phase 3)
Retinal Telangiectasis (Phase 2)
Retinal Vein Occlusion (Phase 2)
Rhinitis (Phase 4)
Rhinitis, Allergic (Phase 4)
Rhinitis, Allergic, Perennial (Phase 4)
Rhinitis, Allergic, Seasonal (Phase 4)
Rhinitis, Vasomotor (Phase 4)
Sjogren's Syndrome (Phase 4)
Syndrome (Phase 3)
Telangiectasis (Phase 2)
Tissue Adhesions (Phase 4)
Uveitis (Phase 3)
Uveitis, Anterior (Phase 3)
Uveitis, Posterior (Phase 1)
Wet Macular Degeneration (Phase 3)
Xerophthalmia (Phase 3)
